Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Rep. Tauzin to head PhRMA: Louisiana Republican Billy Tauzin will take the reins of the Pharmaceutical Research & Manufacturers of America on Jan. 3. The Dec. 15 announcement concludes 10 months of discussion between PhRMA and the former House Energy & Commerce Committee chairman, who will succeed Alan Holmer as head of the drug trade group. Earlier this year, Rep. Jim Greenwood (R-Penn.), a key sponsor of original MDUFMA legislation, was recruited to head the Biotechnology Industry Organization, effective Jan. 5. Greenwood chaired the Energy & Commerce/Oversight & Investigations Subcommittee...

You may also be interested in...



CDRH Division Director Witten Leaves Device Center To Lead CBER Office

Miriam Provost, PhD, is serving as acting head of the device center's Division of General, Restorative & Neurological Devices (DGRND) following the departure of division director Celia Witten

CDRH Division Director Witten Leaves Device Center To Lead CBER Office

Miriam Provost, PhD, is serving as acting head of the device center's Division of General, Restorative & Neurological Devices (DGRND) following the departure of division director Celia Witten

Abiomed Paves Bridge-To-Recovery Market On Road To Destination Therapy

Abiomed is refocusing its ventricular-assist device (VAD) sales efforts on open-heart surgery instead of transplant centers to climb out of an unprofitable quarter and sequential loss of revenue

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel